Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins

被引:52
作者
Memisoglu, E
Bochot, A
Sen, M
Duchêne, D
Hincal, AA [1 ]
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Dept Chem, TR-06532 Ankara, Turkey
[3] Univ Paris 11, Fac Pharm, Lab Physicochim Pharmacotechnie & Biopharm, UMR 8612, F-92296 Chatenay Malabry, France
[4] Hacettepe Univ, Dept Chem, TR-06532 Ankara, Turkey
关键词
amphiphilic beta-cyclodextrin; nanosphere; inclusion complex; progesterone; loading capacity; drug release;
D O I
10.1016/S0378-5173(02)00593-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Amphiphilic beta-cyclodextrins were formulated as nanospheres and characterised by particle size, zeta potential and TEM following freeze-fracture. The nanospheres were loaded with progesterone with different loading techniques involving the spontaneous formation of nanospheres from pre-formed inclusion complexes of amphiphilic beta-cyclodextrins modified on the primary or secondary face with progesterone. Inclusion complexes were characterised with various techniques including Differential Scanning Calorimetry (DSC), Fast Atom Bombardment Mass Spectrometry (FAB MS) and H-1 NMR spectroscopy; and progesterone was believed to be partially included in the CD cavity. Loading properties of conventionally-loaded nanospheres were compared with those prepared directly from pre-formed inclusion complexes and loading technique was found to enhance associated drug percentage significantly (P < 0.05). Although both amphiphilic beta-cyclodextrins (6-N-CAPRO-beta-CD and beta-CDC6) were capable of high progesterone loading, beta-CDC6 displayed slightly higher entrapment efficiency due to the possible higher affinity of progesterone to the 14 alkyl chains surrounding this molecule resulting in higher drug adsorption to particle surface. Progesterone was released within a period of I h from all formulations. Progesterone-loaded amphiphilic beta-CD nanospheres were proved to be a promising non-surfactant injectable delivery system providing high-quantity of water-insoluble progesterone rapidly within I It. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 22 条
[1]  
[Anonymous], MICROENCAPSULATION M
[2]   Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins [J].
Cavalli, R ;
Peira, E ;
Caputo, O ;
Gasco, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) :59-69
[3]   Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs [J].
da Silveira, AM ;
Ponchel, G ;
Puisieux, F ;
Duchêne, D .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1051-1055
[4]   NUCLEAR-MAGNETIC-RESONANCE INVESTIGATION OF THE STOICHIOMETRIES IN BETA-CYCLODEXTRIN - STEROID INCLUSION COMPLEXES [J].
DJEDAINI, F ;
PERLY, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (12) :1157-1161
[5]   Cyclodextrins in targeting -: Application to nanoparticles [J].
Duchêne, D ;
Ponchel, G ;
Wouessidjewe, D .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :29-40
[6]  
FESSI H, 1988, Patent No. 5118529
[7]   PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug [J].
Govender, T ;
Stolnik, S ;
Garnett, MC ;
Illum, L ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) :171-185
[8]   Industrial applications of cyclodextrins [J].
Hedges, AR .
CHEMICAL REVIEWS, 1998, 98 (05) :2035-2044
[9]  
Lemos-Senna E., 1998, PHARM DEV TECHNOL, V3, P1
[10]   Phase behavior of fully hydrated DMPC-amphiphilic cyclodextrin systems [J].
Lesieur, S ;
Charon, D ;
Lesieur, P ;
Ringard-Lefebvre, C ;
Muguet, V ;
Duchêne, D ;
Wouessidjewe, D .
CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 106 (02) :127-144